Personal tools

Coexpression cluster:C1549

From FANTOM5_SSTAR

Revision as of 13:52, 5 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1549_breast_liver_Sebocyte_Hepatocyte_pancreas_Bronchial_Prostate



Phase1 CAGE Peaks

Hg19::chr9:139379041..139379050,-p@chr9:139379041..139379050
-
Hg19::chr9:139379054..139379061,-p@chr9:139379054..139379061
-
Hg19::chr9:139379069..139379135,-p@chr9:139379069..139379135
-
Hg19::chr9:139379145..139379159,-p@chr9:139379145..139379159
-
Hg19::chr9:139379164..139379180,-p@chr9:139379164..139379180
-
Hg19::chr9:139379206..139379215,-p@chr9:139379206..139379215
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell2.85e-35254
endodermal cell2.65e-2059
endo-epithelial cell3.72e-1943
epithelial cell of alimentary canal9.50e-1021
respiratory epithelial cell2.79e-0913
general ecto-epithelial cell2.50e-0813
Uber Anatomy
Ontology termp-valuen
endoderm-derived structure3.41e-31169
endoderm3.41e-31169
presumptive endoderm3.41e-31169
digestive system7.31e-27155
digestive tract7.31e-27155
primitive gut7.31e-27155
mixed endoderm/mesoderm-derived structure4.24e-21130
respiratory system4.53e-2172
subdivision of digestive tract9.76e-20129
endodermal part of digestive tract9.76e-20129
foregut7.11e-1998
endo-epithelium3.72e-1782
respiratory tract1.13e-1453
mesenchyme4.57e-14238
entire embryonic mesenchyme4.57e-14238
multi-tissue structure1.49e-13347
organism subdivision5.65e-12365
segment of respiratory tract6.10e-1246
respiratory primordium2.87e-1138
endoderm of foregut2.87e-1138
immaterial anatomical entity5.16e-11126
gland5.31e-1159
orifice8.19e-1135
surface structure1.55e-1095
gut epithelium2.29e-1054
mouth8.99e-1028
stomodeum8.99e-1028
oral opening1.18e-0921
organ1.30e-09511
exocrine gland2.69e-0931
exocrine system2.69e-0931
epithelial bud4.61e-0937
primordium4.94e-09168
epithelial fold1.46e-0851
subdivision of trunk2.15e-08113
trunk region element3.74e-08107
anatomical space5.12e-08104
trunk5.84e-08216
thoracic cavity element2.38e-0734
thoracic cavity2.38e-0734
anatomical group6.38e-07626
thoracic segment organ6.57e-0735
upper respiratory tract9.42e-0719
Disease
Ontology termp-valuen
carcinoma8.08e-25106
cell type cancer7.32e-16143
squamous cell carcinoma4.32e-0914
cancer4.01e-07235
disease of cellular proliferation4.02e-07239


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
FOXA1#3169611.08141974938555.39600313513231e-072.51137776929627e-05
MXI1#460169.96157162875931.02262624227062e-064.30827196920133e-05
MYC#460965.22228187160944.92821127172503e-050.000854979164464603
POLR2A#543062.147453176558070.01019570676818780.0380799420363611
USF1#739166.361499277207961.50818327938273e-050.000357172683708511



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.